Physician profile
Robert A Sabo
NPI 1780733618
$2,248.22
in general payments reported to CMS, 2019-2025
13 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $258 · 2020: $406 · 2021: $170 · 2022: $155 · 2023: $56.48 · 2024: $1,045 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $806 · Food and Beverage: $453.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $805.92 |
| Food and Beverage | $453.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $864.35 | 2024 | Velys |
| Si-Bone, INC. | $349.00 | 2020-2024 | |
| Nevro Corp. | $239.24 | 2019 | |
| Depuy Synthes Sales INC. | $182.13 | 2019-2025 | Spine & Trauma 3d Navigation, Symphony |
| Abbott Laboratories | $180.73 | 2020-2025 | Eterna, Penta |
| Orthofix Medical, INC. | $146.58 | 2020 | |
| Medtronic, INC. | $118.52 | 2021 | |
| Intrinsic Therapeutics | $50.91 | 2025 | Barricaid Acd (Annular Closure Device) |
| Stryker Corporation | $38.73 | 2023 | Prolift, Vitoss |
| Boston Scientific Corporation | $23.54 | 2025 | General - Therapies |
| Spinal Elements, INC. | $22.05 | 2024 | |
| Ethicon US, LLC | $17.75 | 2023 | Stratafix, Dermabond |
| Siemens Medical Solutions USA, INC. | $14.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sabo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.